FIGO 2018 staging of cervical cancer and related issues

VernacularTitle: 国际妇产科联盟2018年宫颈癌分期及有关问题
Author: Jiandong WANG ¹ ; Weimin KONG ; Hao JIANG
Author Information

1. Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China
Publication Type:Review
Keywords: The International Federation of Gynecology and Obstetrics; Uterine cervical carcinoma; Staging; Prevention and treatment
From: Chinese Journal of Oncology 2020;42(2):94-98
CountryChina
Language:Chinese
Abstract: Globally, cervical cancer continues to be one of the most common cancers among females. Although screening for cervical cancer has been gradually carried out, the incidence and mortality of cervical cancer in China are still at a high level. So the prevention and treatment of cervical cancer in China still has lots of work to do. The International Federation of Obstetrics and Gynecology (FIGO) gynecological oncology committee revised the staging of cervical cancer in 2018. The new staging changed in terms of stage ⅠB and stage Ⅲ compared with previous FIGO staging. FIGO also provided prevention and treatment strategies and the treatment regimens of each stage, which had an important impact on the prevention and treatment of cervical cancer as well as an important enlightenment for China.